Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2026-08-18 17:10:25 ET · period of report 2026-08-15 · accession 0001628280-26-057751 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 17:10 | 2026-08-15 | MDGL | REED JOHN C | Dir | A - Grant | $0.00 | +647 | 647 | New | $0 |
| D | 2026-08-18 17:10 | 2026-08-15 | MDGL | REED JOHN C | Dir | A - Grant | $0.00 | +1,078 | 1,078 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-15 | A | A | 647 | $0.00 | 647 | D | — | — | (F1) Represents a grant of restricted stock units which vest as to 50% of the shares on each of August 15, 2027 and August 15, 2028, provided the Reporting Person continues in service with the Issuer on each such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-08-15 | A | A | 1,078 | $0.00 | 1,078 | D | $507.56 · — to 2036-08-15 | 1,078 Common Stock | (F2) The option vests as to 50% of the shares on the first anniversary of the date of grant (August 15, 2027), and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period for four successive three-month periods, provided the Reporting Person continues in service with the Issuer on each such date. |